Hearing therapeutics are advancing rapidly, but how close are we to real breakthroughs? That was the focus of The State of Hearing Therapeutics, a panel discussion held during the 2025 Hearing Therapeutics Summit on February 4.
Moderated by Brian Taylor, AuD, the panel featured Hugo Peris (Spiral Therapeutics), Tony Ricci, PhD (Stanford University School of Medicine), Jian Zuo, PhD (Ting Therapeutics), Dr. Douglas Hartley (Rinri Therapeutics), and Jonas Dyhrfjeld-Johnsen, PhD (Acousia Therapeutics). The discussion provided a deep dive into the latest advancements in hearing restoration, including gene therapy, regenerative medicine, and pharmaceutical approaches to treating sensorineural hearing loss. Panelists explored the current state of clinical research, regulatory pathways, and the challenges of bringing novel hearing therapeutics to market. They also discussed the growing role of precision medicine and targeted drug delivery in shaping the future of hearing healthcare. As scientific breakthroughs continue, collaboration across academia, industry, and clinical practice will be critical in accelerating the development of effective treatments. Be sure to subscribe to our YouTube channel for the latest episodes each week, and follow This Week in Hearing on LinkedIn and X (formerly Twitter):
- https://www.linkedin.com/company/this-week-in-hearing/
- https://twitter.com/WeekinHearing
Informations
- Émission
- FréquenceChaque semaine
- Publiée6 février 2025 à 13:00 UTC
- Durée59 min
- ClassificationTous publics